Search results for "Myocardial infarction"
Self-reported pain after MI associated with long-term all-cause mortality
Researchers in Sweden found that patients who had had a myocardial infarction (MI) and reported moderate or severe musculoskeletal pain one year after hospital discharge were at higher risk for death than those without pain.
https://immattersacp.org/weekly/archives/2023/08/22/1.htm
22 Aug 2023
SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout
New users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had about half the risk of an ED visit or hospitalization for a gout flare as matched patients taking dipeptidyl peptidase-4 inhibitors, a cohort analysis found.
https://immattersacp.org/weekly/archives/2023/07/25/1.htm
25 Jul 2023
Intensive blood pressure control effective in older frail patients, study finds
Data from SPRINT indicated that frail patients were at higher risk for cardiovascular events than nonfrail patients and benefited similarly from a blood pressure target of less than 120 mm Hg, with no significant increase in adverse events.
https://immattersacp.org/weekly/archives/2023/07/11/2.htm
11 Jul 2023
Cardiovascular effects of vitamin D supplementation still uncertain, trial finds
Older adults who were randomized to vitamin D supplementation had a slightly lower rate of cardiovascular events, particularly myocardial infarction, but the overall difference from placebo was not significant, an Australian trial found.
https://immattersacp.org/weekly/archives/2023/07/04/4.htm
4 Jul 2023
RSV vaccine approved; several actions on opioids
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
Patients may respond differently to different hypertension drug classes
The authors of a randomized, double-blind, repeated crossover trial in Sweden estimated that personalized antihypertensive therapy could yield an average reduction in systolic blood pressure of 4.4 mm Hg compared to fixed-choice therapy.
https://immattersacp.org/weekly/archives/2023/04/18/1.htm
18 Apr 2023
CTA-detected coronary artery disease associated with increased risk for myocardial infarction
Danish researchers used computed tomography angiography (CTA) to diagnose obstructive coronary atherosclerosis in 9,533 asymptomatic patients ages 40 years or older without known cardiovascular disease.
https://immattersacp.org/weekly/archives/2023/03/28/2.htm
28 Mar 2023
MKSAP Quiz: Motivating lifestyle change
A 28-year-old man is evaluated during a follow-up visit for hypertension and diabetes mellitus. He works two jobs and eats fast food for most meals. Which of the following is the most appropriate management?
https://immattersacp.org/weekly/archives/2023/03/21/3.htm
21 Mar 2023
Separate industry-funded studies find benefit to bempedoic acid as preventive medication, CRP as biomarker
Bempedoic acid reduced cardiovascular (CV) events among patients unwilling or unable to take statins, a trial found, while a review showed that high-sensitivity C-reactive protein (CRP) was a stronger predictor for risk of future CV events and death than cholesterol in patients on statins.
https://immattersacp.org/weekly/archives/2023/03/14/4.htm
14 Mar 2023